Caffeine for Prevention of Alzheimer’s Disease: Is the A(2A) Adenosine Receptor Its Target?

Alzheimer’s disease (AD) is the most prevalent kind of dementia with roughly 135 million cases expected in the world by 2050. Unfortunately, current medications for the treatment of AD can only relieve symptoms but they do not act as disease-modifying agents that can stop the course of AD. Caffeine...

Descripción completa

Detalles Bibliográficos
Autores principales: Merighi, Stefania, Travagli, Alessia, Nigro, Manuela, Pasquini, Silvia, Cappello, Martina, Contri, Chiara, Varani, Katia, Vincenzi, Fabrizio, Borea, Pier Andrea, Gessi, Stefania
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296091/
https://www.ncbi.nlm.nih.gov/pubmed/37371547
http://dx.doi.org/10.3390/biom13060967

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296091/
https://www.ncbi.nlm.nih.gov/pubmed/37371547
http://dx.doi.org/10.3390/biom13060967

Ejemplares similares